Medically reviewed by Patricia Mikula, PharmD Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes and obesity. They are in a class of drugs known as incretin ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity ... market is categorized by drug type into GLP-1 receptor agonists and DPP-4 inhibitors, with a market ...

New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight ...